Literature DB >> 26923928

Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.

Nipaporn Tewawong1, Jira Chansaenroj1, Sirapa Klinfueng1, Preeyaporn Vichiwattana1, Sumeth Korkong1, Thanunrat Thongmee1, Apiradee Theamboonlers1, Sunchai Payungporn2, Sompong Vongpunsawad1, Yong Poovorawan3.   

Abstract

Influenza B viruses comprise two lineages, Victoria (B/Vic) and Yamagata (B/Yam), which co-circulate globally. The surveillance data on influenza B virus lineages in many countries often underestimate the true prevalence due to the lack of a rapid, accurate, and cost-effective method for virus detection. We have developed a real-time PCR with melting curve analysis for lineage-specific differential detection of influenza B virus. By amplifying a region of the hemagglutinin gene using real-time PCR with SYBR Green I dye, B/Vic and B/Yam could be differentiated based on their melting temperature peaks. This method was efficient (B/Vic = 93.2 %; B/Yam 97.7 %), sensitive (B/Vic, 94.6 %; B/Yam, 96.3 %), and specific (B/Vic, 97.7 %; B/Yam, 97.1 %). The lower detection limit was 10(2) copies per microliter. The assay was evaluated using 756 respiratory specimens that were positive for influenza B virus, obtained between 2010 and 2015. The incidence of influenza B virus was approximately 18.9 % of all influenza cases, and the percentage was highest among children aged 6-17 years (7.57 %). The overall percentage of mismatched influenza B vaccine was 21.1 %. Our findings suggest that real-time PCR with melting curve analysis can provide a rapid, simple, and sensitive lineage-specific influenza B virus screening method to facilitate influenza surveillance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26923928     DOI: 10.1007/s00705-016-2802-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Genome characterization and mutation analysis of human influenza A virus in Thailand.

Authors:  Somruthai Rattanaburi; Vorthon Sawaswong; Pattaraporn Nimsamer; Oraphan Mayuramart; Pavaret Sivapornnukul; Ariya Khamwut; Prangwalai Chanchaem; Kritsada Kongnomnan; Nungruthai Suntronwong; Yong Poovorawan; Sunchai Payungporn
Journal:  Genomics Inform       Date:  2022-06-30

2.  A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.

Authors:  Bindumadhav M Marathe; Heba H Mostafa; Peter Vogel; Philippe Noriel Q Pascua; Jeremy C Jones; Charles J Russell; Richard J Webby; Elena A Govorkova
Journal:  Antiviral Res       Date:  2017-10-31       Impact factor: 5.970

3.  Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.

Authors:  Nungruthai Suntronwong; Sirapa Klinfueng; Preeyaporn Vichiwattana; Sumeth Korkong; Thanunrat Thongmee; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

4.  Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.

Authors:  Nipaporn Tewawong; Preeyaporn Vichiwattana; Sumeth Korkong; Sirapa Klinfueng; Nungruthai Suntronwong; Thanunrat Thongmee; Apiradee Theamboonlers; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

5.  An Inexpensive and Accurate Reverse Transcription-PCR-Melting Temperature Analysis Assay for Real-Time Influenza Virus B Lineage Discrimination.

Authors:  Fernando Couto Motta; Priscila Silva Born; Paola Cristina Resende; David Brown; Marilda Mendonça Siqueira
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

6.  Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017-2020.

Authors:  Nungruthai Suntronwong; Sirapa Klinfueng; Sumeth Korkong; Preeyaporn Vichaiwattana; Thanunrat Thongmee; Sompong Vongpunsawad; Yong Poovorawan
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.